The Latest Breaking News from Moderna

Has Moderna successfully developed a personalised vaccine against melanoma? Maybe

Moderna has partnered with another drug company to produce a personalised vaccine against melanoma for people at risk of dying.

The New Daily · Dec 14, 2022

Skin cancer vaccine trial shows promising results

Moderna and Merck team up in new study.

Fortune · Dec 13, 2022

Researchers from Moderna and Merck just made a breakthrough with a skin cancer vaccine

Thank you, science.

Mic · Dec 13, 2022

Former vaccines chief sounds warning about UK pandemic readiness

Kate Bingham raises concerns to committee of MPs as head of UKHSA suggests Covid could be on rise again

The Guardian - UK · Nov 30, 2022

Racing to develop Africa’s next-gen vaccines before new pandemic

How scientists across Africa plan to use mRNA technology to fight diseases and tackle inequities in global health.

Al Jazeera · Nov 30, 2022

Universal flu vaccine could be ready for human use in two years – expert

The US researchers have created a vaccine based on the same mRNA technology used in the Covid-19 jabs from Moderna and Pfizer.

The Independent UK · Nov 25, 2022

Researchers test mRNA technology for universal flu vaccine

An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway to a universal flu shot that might help prevent future pandemics, according to a U.S. study published on Thursday.

Reuters · Nov 24, 2022

US renews push for COVID boosters as data show they protect

Americans who have gotten the updated COVID-19 boosters appear better protected against symptomatic infection than those who haven't — at least for now

The Independent UK · Nov 22, 2022

RSV: experts explain why rates of this virus are surging this year

Respiratory syncytial virus (RSV) is a very common virus, typically causing infection in children during the colder months. In most cases, RSV causes a mild illness, with symptoms similar to that of a regular cold.

The Conversation · Nov 18, 2022

Pfizer booster spurs immune response to new omicron subtypes

Pfizer said its updated COVID-19 booster may offer some protection against newly emerging omicron mutants even though it’s not an exact match

The Independent UK · Nov 18, 2022